全文获取类型
收费全文 | 5097篇 |
免费 | 277篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 215篇 |
妇产科学 | 79篇 |
基础医学 | 412篇 |
口腔科学 | 154篇 |
临床医学 | 540篇 |
内科学 | 1303篇 |
皮肤病学 | 66篇 |
神经病学 | 233篇 |
特种医学 | 126篇 |
外国民族医学 | 1篇 |
外科学 | 1085篇 |
综合类 | 73篇 |
一般理论 | 1篇 |
预防医学 | 320篇 |
眼科学 | 119篇 |
药学 | 319篇 |
中国医学 | 27篇 |
肿瘤学 | 278篇 |
出版年
2023年 | 38篇 |
2022年 | 95篇 |
2021年 | 185篇 |
2020年 | 91篇 |
2019年 | 149篇 |
2018年 | 215篇 |
2017年 | 123篇 |
2016年 | 145篇 |
2015年 | 138篇 |
2014年 | 291篇 |
2013年 | 298篇 |
2012年 | 461篇 |
2011年 | 495篇 |
2010年 | 270篇 |
2009年 | 200篇 |
2008年 | 330篇 |
2007年 | 328篇 |
2006年 | 314篇 |
2005年 | 237篇 |
2004年 | 247篇 |
2003年 | 210篇 |
2002年 | 224篇 |
2001年 | 31篇 |
2000年 | 13篇 |
1999年 | 27篇 |
1998年 | 30篇 |
1997年 | 28篇 |
1996年 | 24篇 |
1995年 | 17篇 |
1994年 | 16篇 |
1993年 | 16篇 |
1992年 | 12篇 |
1991年 | 9篇 |
1990年 | 10篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 7篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 11篇 |
1979年 | 3篇 |
1977年 | 5篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1962年 | 2篇 |
排序方式: 共有5405条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy 总被引:5,自引:0,他引:5
Pockros PJ Shiffman ML Schiff ER Sulkowski MS Younossi Z Dieterich DT Wright TL Mody SH Tang KL Goon BL Bowers PJ Leitz G Afdhal NH;PROACTIVE Study Group 《Hepatology (Baltimore, Md.)》2004,40(6):1450-1458
Anemia and decreased health-related quality of life (HRQL) are common in patients receiving combination therapy of interferon alfa (IFN) and ribavirin (RBV) for chronic hepatitis C virus (HCV) infection. In a randomized, prospective study evaluating the effectiveness of epoetin alfa in maintaining RBV dose, alleviating anemia, and improving HRQL in anemic (Hb < or = 12 g/dL) HCV-infected patients receiving combination therapy, patients receiving epoetin alfa had significant improvements in HRQL compared with placebo. In this study, 185 patients were randomized to 40,000 units of epoetin alfa subcutaneously weekly or placebo for an 8-week double-blind phase (DBP), followed by an 8-week open-label phase during which all patients received epoetin alfa. To further assess the impact of epoetin alfa on HRQL, post hoc analyses were conducted in the same patient population to compare the HRQL of these patients at randomization with norms of other populations, and to determine the critical relationship between hemoglobin (Hb) levels and HRQL. Mean HRQL scores of anemic HCV-infected patients receiving combination therapy at randomization were significantly lower than those of both the general population and patients who had other chronic conditions. Patients receiving epoetin alfa who had the greatest Hb increases from randomization to the end of the DBP also had the largest improvements in HRQL. Hb improvement was an independent predictor of HRQL improvement in these patients. In conclusion, epoetin alfa provided clinically significant HRQL improvement in HCV-infected patients receiving IFN/RBV therapy. 相似文献
105.
Chandra C. Ghosh Sascha David Ruyang Zhang Anthony Berghelli Katelyn Milam Sarah J. Higgins Jon Hunter Aditi Mukherjee Yongyue Wei Mei Tran Freeman Suber Lester Kobzik Kevin C. Kain Shulin Lu Ansgar Santel Kiichiro Yano Prajna Guha Daniel J. Dumont David C. Christiani Samir M. Parikh 《Proceedings of the National Academy of Sciences of the United States of America》2016,113(9):2472-2477
Ligands of the endothelial-enriched tunica interna endothelial cell kinase 2 (Tie2) are markedly imbalanced in severe infections associated with vascular leakage, yet regulation of the receptor itself has been understudied in this context. Here, we show that TIE2 gene expression may constitute a novel vascular barrier control mechanism in diverse infections. Tie2 expression declined rapidly in wide-ranging models of leak-associated infections, including anthrax, influenza, malaria, and sepsis. Forced Tie2 suppression sufficed to attenuate barrier function and sensitize endothelium to permeability mediators. Rapid reduction of pulmonary Tie2 in otherwise healthy animals attenuated downstream kinase signaling to the barrier effector vascular endothelial (VE)-cadherin and induced vascular leakage. Compared with wild-type littermates, mice possessing one allele of Tie2 suffered more severe vascular leakage and higher mortality in two different sepsis models. Common genetic variants that influence TIE2 expression were then sought in the HapMap3 cohort. Remarkably, each of the three strongest predicted cis-acting SNPs in HapMap3 was also associated with the risk of acute respiratory distress syndrome (ARDS) in an intensive care unit cohort of 1,614 subjects. The haplotype associated with the highest TIE2 expression conferred a 28% reduction in the risk of ARDS independent of other major clinical variables, including disease severity. In contrast, the most common haplotype was associated with both the lowest TIE2 expression and 31% higher ARDS risk. Together, the results implicate common genetic variation at the TIE2 locus as a determinant of vascular leak-related clinical outcomes from common infections, suggesting new tools to identify individuals at unusual risk for deleterious complications of infection.Among vascular-enriched receptor tyrosine kinases, Tie2 is unusual in at least two functional aspects. First, Tie2 phosphorylation is tightly controlled by the interplay of several proteins: a paralogous receptor, Tie1; a tyrosine phosphatase, vascular endothelial-protein tyrosine phosphatase (VE-PTP); and two secreted ligands, angiopoietin (Angpt)-1 and Angpt-2, the latter of which can act as an agonist, partial agonist, or antagonist depending upon context (1–6). Second, unlike classic growth factor receptors, Tie2 is heavily expressed and phosphorylated throughout the quiescent adult vasculature (7), suggesting that Tie2 signaling has one or more roles in vascular maintenance.Based largely on Angpt-1 overexpression studies, Tie2 has been implicated in vascular barrier defense (8, 9). However, adult-specific deletion of Angpt-1 does not appear to trigger vascular leakage (10). Moreover, Angpt-1 has repeatedly been ascribed functions that are independent of Tie2 (11–13). Finally, observational studies in humans suffering clinical manifestations of vascular leakage have consistently shown a marked imbalance in Tie2 ligands tilting in favor of Angpt-2 (reviewed in 14). Although decreased Tie2 activity has been inferred from these reports, the role of TIE2 gene expression has not been directly queried experimentally or in clinical settings.This question is important not only for understanding control mechanisms of the circulatory system but also to guide the development of strategies to predict, stratify, and treat patients affected by acute vascular leakage. If tonic Tie2 signaling is indeed necessary for vascular barrier maintenance, then reducing the pool of receptors could constitute a ligand-independent means to attenuate barrier-protective signaling in the endothelium. We therefore hypothesized that the level of Tie2 expression modulates the sensitivity of blood vessels, and thereby the entire organism, to noxious stimuli. Cellular, rodent, and human genetics studies were undertaken to test this concept. 相似文献
106.
107.
Giuseppe Citerio Jan Bakker Matteo Bassetti Dominique Benoit Maurizio Cecconi J. Randall Curtis Gordon S. Doig Margaret Herridge Samir Jaber Michael Joannidis Laurent Papazian Anders Perner Mark J. Peters Pierre Singer Martin Smith Marcio Soares Antoni Torres Antoine Vieillard-Baron Jean-François Timsit Elie Azoulay 《Intensive care medicine》2015,41(2):179-191
108.
109.